574 results on '"Jarius S"'
Search Results
2. Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome
3. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature
4. Parvovirus B19 and mumps virus antibodies are major constituents of the intrathecal immune response in European patients with MS and increase the diagnostic sensitivity and discriminatory power of the MRZ reaction
5. Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome
6. Treatment of MOG antibody associated disorders: results of an international survey
7. Devic's index case: A critical reappraisal – AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis?
8. Autoimmune and immunogenetic profile of patients with optic neuritis in a population-based cohort
9. Magnetic resonance imaging findings at the first episode of acute optic neuritis
10. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
11. MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antikörpertestung
12. The history of neuromyelitis optica. Part 2: ‘Spinal amaurosis’, or how it all began
13. Gamma-aminobutyric acid receptor agonists, aquaporin-4, and neuromyelitis optica: a potential link
14. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
15. Myelinoclastic diffuse sclerosis (Schilder’s disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures
16. The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature
17. Autoantikörperassoziierte autoimmune Enzephalitiden und Zerebellitiden: Klinik, Diagnostik und Therapie
18. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
19. MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature
20. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: A potential link
21. Costs and health-related quality of life in patients with NMO spectrum disorders and MOG-antibody-associated disease: CHANCE(NMO) study
22. Biopsie bei tumorverdächtiger spinaler Raumforderung: Fallstrick Neuromyelitis optica
23. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
24. ‘Spinal amaurosis’ (1841). On the early contribution of Edward Hocken to the concept of neuromyelitis optica
25. Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome
26. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen
27. Pain, depression and quality of life in adults with MOG-antibody associated disease
28. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
29. Neuromyelitis optica
30. On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica
31. Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus
32. The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation
33. Susac-Syndrom: Eine interdisziplinäre Herausforderung
34. Diagnostik und Therapie der Neuromyelitis optica: Konsensusempfehlungen der Neuromyelitis optica Studiengruppe
35. Qualitative evidence of Ri specific IgG-synthesis in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes
36. CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis
37. Neuromyelitis optica: clinical features, immunopathogenesis and treatment
38. Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies: EP1130
39. Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases
40. Neuromyelitis optica
41. 7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions
42. Neurological course of long-term surviving patients with SCLC and anti-Hu syndrome
43. Interferontherapie der Multiplen Sklerose: Synopsis der verschiedenen Applikationsformen
44. Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders
45. Homology between Klebsiella pneumoniae and human aquaporin-4: no evidence for cross-reactivity in neuromyelitis optica. A study on 114 patients
46. SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes
47. Two cases of benign neuromyelitis optica in patients with celiac disease
48. Antibodies to aquaporin-4 in non-small cell lung cancer: a study on 50 patients
49. And Pavlov still rings a bell: summarising the evidence for the use of a bell in Pavlov’s iconic experiments on classical conditioning
50. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.